Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of amiodarone in bradycardia-tachycardia syndrome.

Literature DB >> 708517

Use of amiodarone in bradycardia-tachycardia syndrome.

Abstract

Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone. Three patients were treated for over nine months and one of these patients had corneal micro deposits. One patient had to be taken off the drug because of side effects. Amiodarone should be tried in patients suffering from the bradycardia-tachycardia syndrome before resorting to cardiac pacing.

Entities: Chemical Disease Species

Mesh：

Substances：
Benzofurans
Amiodarone

Year: 1978 PMID： 708517 PMCID： PMC483541 DOI： 10.1136/hrt.40.10.1149

Source DB: PubMed Journal: Br Heart J ISSN： 0007-0769

10 in total

Review 1. The sick sinus syndrome.

Authors: M I Ferrer
Journal: Circulation Date: 1973-03 Impact factor: 29.690

2. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

Authors: S B Olsson; L Brorson; E Varnauskas
Journal: Br Heart J Date: 1973-12

3. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.

Authors: R Charlier; G Delaunois; J Bauthier
Journal: Arzneimittelforschung Date: 1972-03

4. Letter: Amiodarone and neurological side-effects.

Authors: F Lustman; G Monseu
Journal: Lancet Date: 1974-03-30 Impact factor: 79.321

5. Clinical spectrum of the sick sinus syndrome.

Authors: J J Rubenstein; C L Schulman; P M Yurchak; R W DeSanctis
Journal: Circulation Date: 1972-07 Impact factor: 29.690

6. Cornea verticillata.

Authors: J François
Journal: Doc Ophthalmol Date: 1969 Impact factor: 2.379

Review 7. Comparative mechanisms of action of antiarrhythmic drugs.

Authors: B N Singh; O Hauswirth
Journal: Am Heart J Date: 1974-03 Impact factor: 4.749

8. [Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].

Authors: J Van Schepdael; H Solvay
Journal: Schweiz Rundsch Med Prax Date: 1975-01-14

9. Clinical efficacy of amiodarone as an antiarrhythmic agent.

Authors: M B Rosenbaum; P A Chiale; M S Halpern; G J Nau; J Przybylski; R J Levi; J O Lázzari; M V Elizari
Journal: Am J Cardiol Date: 1976-12 Impact factor: 2.778

10. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors: B N Singh; E M Vaughan Williams
Journal: Br J Pharmacol Date: 1970-08 Impact factor: 8.739

10 in total

7 in total

7. A new association of multiple congenital anomalies/mental retardation syndrome with bradycardia-tachycardia syndrome: a case report.

Authors: Chinnamuthu Murugesan; Pradeep Kumar; Kanchi Muralidhar
Journal: J Med Case Rep Date: 2009-12-01

7 in total

Use of amiodarone in bradycardia-tachycardia syndrome.

Review 1. The sick sinus syndrome.

2. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

3. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.

4. Letter: Amiodarone and neurological side-effects.

5. Clinical spectrum of the sick sinus syndrome.

6. Cornea verticillata.

Review 7. Comparative mechanisms of action of antiarrhythmic drugs.

8. [Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].

9. Clinical efficacy of amiodarone as an antiarrhythmic agent.

10. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Review 1. New antiarrhythmic drugs: their place in therapy.

Review 2. Adverse effects of antiarrhythmic drugs.

3. Use of amiodarone in bradycardia-tachycardia syndrome.

4. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.

5. Adverse reactions during treatment with amiodarone hydrochloride.

6. Oral xamoterol in patients with sinoatrial disease.

7. A new association of multiple congenital anomalies/mental retardation syndrome with bradycardia-tachycardia syndrome: a case report.